UNIQUE VALUE & OFFERINGS
We get it.
You need market access research you can trust.
That’s why we built a better way.
Do you want to ensure your market access insights are more current than your competitor’s?
Primary Payer Market Research
Formulary Insights enables commercial success through its suite of products which harvest insights to inform market access strategies regarding pipeline, business development & licensing (BD&L), inline brands, and healthcare ecosystems.
FORMULARY INSIGHTS RAPID STUDY TOOL
The most agile market access research platform on the market. Allows teams to optimize the timeliness of insights without compromising quality
Strategic decisions are only as good as the insights they are built upon.
You need insights fast, but you can’t afford to compromise on quality.
A reserve of market access studies which can be deployed on short notice without compromising quality. The product of choice for BD&L and pipeline teams.
Research designed by Formulary Insights on topics of high interest
All the benefits of our Core Research studies without the compliance requirements of developing your own
Many in biopharma have a responsibility to ensure they remain alert to all market access landscape trends.
Standard research can be difficult to execute due to a wide range of internal oversight processes.
Recurring research designed and executed by Formulary Insights so that you can spend less time coordinating approvals and more time developing strategy.
Your opportunity for exhaustive research on key areas of interest
Deep-dive research to ensure a complete understanding of payer interests and impressions
Market access insights should only come from active market access decision makers at major payers, IDNs and specialty pharmacies.
Most market access research panels include retirees and loosely affiliated “experts”.
A comprehensive deep-dive into specific areas of interest with the single best US market access panel available today.
HOW WE ARE BETTER
Experienced market access experts at your side from start-to-finish
Only active market access decision makers… no retirees, no loose affiliations
Agile research unleashes progressive learning and more actionable insights